Soft tissue implant sales set to nearly double in next three years
This article was originally published in Clinica
Executive Summary
With an expected annual growth rate averaging 14-20% over the next few years, US sales of soft tissue implants (STI) are set to increase by almost 90% on current figures to exceed $700 million by 2002, predicts a new Theta report. These figures reflect the huge sales potential and growth within the STI market for companies to exploit innovative technologies and establish firm competitive positions.